Diamant M, Tushuizen M E, Sturk A, Nieuwland R
VU Medisch Centrum, afd. Endocrinologie/Diabetescentrum, Postbus 7057, 1007 MB Amsterdam.
Ned Tijdschr Geneeskd. 2004 Jul 10;148(28):1376-80.
In virtually all eukaryotic cells, activation and apoptosis lead to the formation of vesicles or microparticles by intracellular mechanisms which as yet are not completely understood. Flow cytometry, electron microscopy and ELISA techniques can be used to detect microparticles. Microparticles are a heterogeneous population and their numbers, cellular origin, composition and functional characteristics, both in vitro and in vivo, depend on the circumstances under which they were generated. Microparticles derived from various cells, primarily platelets but also lymphocytes, granulocytes, monocytes, erythrocytes and endothelial cells, are present in the circulation of healthy subjects. Elevated numbers of microparticles can be found in a wide variety of diseases, all of which are associated with hypercoagulability and blood-vessel damage, thus suggesting their role in the pathogenesis of vascular disease.
在几乎所有真核细胞中,激活和凋亡会通过尚未完全明确的细胞内机制导致囊泡或微粒的形成。流式细胞术、电子显微镜和酶联免疫吸附测定技术可用于检测微粒。微粒是一个异质性群体,其数量、细胞来源、组成及功能特性,无论在体外还是体内,均取决于其产生时的环境。来源于各种细胞的微粒,主要是血小板,也有淋巴细胞、粒细胞、单核细胞、红细胞和内皮细胞,存在于健康受试者的循环系统中。在多种疾病中均可发现微粒数量升高,所有这些疾病都与高凝状态和血管损伤相关,因此提示它们在血管疾病发病机制中发挥作用。